209 related articles for article (PubMed ID: 10213343)
1. Improved knowledge of antidiabetic treatment--a necessity for the modern cardiologist.
Wikström G; Malmberg K; Rydén L
Eur Heart J; 1999 Mar; 20(6):403-5. PubMed ID: 10213343
[No Abstract] [Full Text] [Related]
2. [Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus].
Ametov AS; P'ianykh OP; Chernikova NA
Ter Arkh; 2010; 82(8):71-5. PubMed ID: 20873250
[TBL] [Abstract][Full Text] [Related]
3. Diabetic cardiovascular disease lost in translation between endocrinology and cardiology.
Dagdelen S
Am J Cardiol; 2008 Oct; 102(8):1115-6. PubMed ID: 18929722
[No Abstract] [Full Text] [Related]
4. [Intensive blood glucose lowering to reduce cardiovascular risk: contra].
Marx N
Dtsch Med Wochenschr; 2009 May; 134(20):1061. PubMed ID: 19421930
[No Abstract] [Full Text] [Related]
5. [Intensive blood glucose lowering to reduce cardiovascular risk: pro].
Martin S
Dtsch Med Wochenschr; 2009 May; 134(20):1060. PubMed ID: 19421929
[No Abstract] [Full Text] [Related]
6. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
Malesker MA
Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
[TBL] [Abstract][Full Text] [Related]
7. Does intensive glycemic control improve cardiovascular outcomes?
Pendergrass M
Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
[No Abstract] [Full Text] [Related]
8. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
Laakso M
Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
[No Abstract] [Full Text] [Related]
9. STOP-NIDDM: a new paradigm for diabetes prevention?
Hanefeld M
Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):253-8. PubMed ID: 12616804
[No Abstract] [Full Text] [Related]
10. [Glitazones critically evaluated].
Schernthaner G
Dtsch Med Wochenschr; 2007 Dec; 132(49):2619. PubMed ID: 18050024
[No Abstract] [Full Text] [Related]
11. [Too positive comment on glitazones].
Lindberg M
Ugeskr Laeger; 2007 Feb; 169(8):733; author reply 733. PubMed ID: 17338040
[No Abstract] [Full Text] [Related]
12. Implications of thiazolidinedione use and cardiovascular risk: is it all about the sugar?
Krantz MJ
Pharmacotherapy; 2006 Jul; 26(7):1049; discussion 1049-50. PubMed ID: 16803430
[No Abstract] [Full Text] [Related]
13. [Clinical advances in diabetes].
Martin S; Scherbaum WA
Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1461-2. PubMed ID: 16794976
[No Abstract] [Full Text] [Related]
14. [Cardioprotection by acarbose--pro].
Breuer HW
Dtsch Med Wochenschr; 2004 May; 129(20):1155. PubMed ID: 15143459
[No Abstract] [Full Text] [Related]
15. [World news in age-related diabetes: blood sugar lowering can improve prognosis].
Einecke D
MMW Fortschr Med; 2005 Sep; 147(38):1. PubMed ID: 16218218
[No Abstract] [Full Text] [Related]
16. [Cardioprotection by acarbose--contra].
Kaiser T; Sawicki PT
Dtsch Med Wochenschr; 2004 May; 129(20):1156. PubMed ID: 15143460
[No Abstract] [Full Text] [Related]
17. [Diabetes screening and early therapy. Feasible and successful].
MMW Fortschr Med; 2010 Oct; 152(40):16. PubMed ID: 21053403
[No Abstract] [Full Text] [Related]
18. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
Hemmingsen B; Lund SS; Vaag A
Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
[TBL] [Abstract][Full Text] [Related]
19. [Primary combined oral antidiabetic therapy in type-2 diabetes mellitus].
Winkler G; Baranyi E
Orv Hetil; 2002 Oct; 143(43):2441-7. PubMed ID: 12455146
[TBL] [Abstract][Full Text] [Related]
20. [Diabetology 2007].
Scherbaum WA
Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1407-10. PubMed ID: 17570091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
